These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5313449)

  • 1. Mass immunization of children in Iran with live attenuated Sugiyama measles virus adapted to calf kidney cell cultures.
    Mirchamsy H; Shafyi A; Bahrami S; Nazari P; Mirzadeh M; Bassali Y
    Jpn J Exp Med; 1971 Feb; 41(1):39-48. PubMed ID: 5313449
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 3. Increasing attenuation of measles virus strain Sugiyama during serial passage in calf kidney cells.
    Kawana R; Kaneko M; Wako H; Iwai T; Kawana M
    Jpn J Exp Med; 1970 Aug; 40(4):257-63. PubMed ID: 5312395
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study on two further attenuated live measles virus vaccines, "CAM" and "Moraten".
    Sangkawibha N; Tuchinda P; Bukkavesa S; Osatanonda P; Ueda S
    Biken J; 1971 Mar; 14(1):77-9. PubMed ID: 5090682
    [No Abstract]   [Full Text] [Related]  

  • 6. [Measles vaccination of pre-school children: a detailed study of reaction frequency and side effects after immunization with vaccine of 3 different strengths].
    Böttiger M; Heller L; Kamensky P; Svanberg B
    Lakartidningen; 1974 Sep; 71(36):3270-4. PubMed ID: 4410083
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
    Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
    Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigation and appplication of the USSR AMS live measles vaccine from the ESC strain for mass vaccination against measles.
    Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):1-18. PubMed ID: 4985647
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on further attenuated live measles vaccine. V. Immunization test of CAM-A4 measles vaccine on handicapped children.
    Ueda S; Okuno Y; Sakamoto Y
    Biken J; 1970 Sep; 13(3):175-8. PubMed ID: 4249672
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.
    Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
    Pediatrics; 1969 Apr; 43(4):567-72. PubMed ID: 4304934
    [No Abstract]   [Full Text] [Related]  

  • 11. Live measles vaccine prepared in dog kidney cells. 3. Vaccination against measles with Czechoslovak live vaccine.
    Adam E; Kratochvílova M; Mares I; Drevo M; Závadová H
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(2):232-9. PubMed ID: 5330077
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon in congenital rubella: response to live attenuated measles vaccine.
    Desmyter J; Rawls WE; Melnick JL; Yow MD; Barrett FF
    J Immunol; 1967 Oct; 99(4):771-7. PubMed ID: 4963794
    [No Abstract]   [Full Text] [Related]  

  • 13. [Specific anti-measles prophylaxis in Rumania. 3. Comparative study of some live attenuated virus vaccines].
    Cajal N; Cepleanu M; Cernescu C; Sorodoc Y
    Stud Cercet Inframicrobiol; 1969; 20(4):275-85. PubMed ID: 5371258
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of clinical and serological results after intramuscular and subcutaneous administration of measles vaccine].
    Domorázková E; Drevo M; Bergmannová V; Stehlíková J; Vodicková M; Slonim D
    Cesk Pediatr; 1982 Jan; 37(1):19-22. PubMed ID: 7060187
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental study of a further attenuated live measles vaccine of the Sugiyama strain in Iran.
    Mirchamsy H; Shafyi A; Rafyi MR; Bahrami S; Nazari P; Fatemie S
    J Hyg (Lond); 1974 Apr; 72(2):273-9. PubMed ID: 4522721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibody status following live measles vaccine--3 years postvaccination].
    Schumacher H; Welbers de Liddle IB
    Dtsch Med Wochenschr; 1970 Jul; 95(31):1594-8. PubMed ID: 5431984
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoglobulin classes of antibodies produced by inoculation of attenuated live measles vaccine].
    Sekiguchi H; Numazaki Y; Ikeda M; Yano N
    Iryo; 1970 Jan; 24(1):21-3. PubMed ID: 4191377
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of extremely attenuated live measles virus vaccine (CAM-EX).
    Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
    Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vaccination against measles].
    Cocchi P; Corti R
    Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.